Journal: Journal of Neuroinflammation
Article Title: Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain
doi: 10.1186/s12974-019-1476-6
Figure Lengend Snippet: ASK1 inhibitor NQDI1 attenuated CCI-induced neuropathic pain and decreased the expression of p-p38 and p-JNK. a , b Single administration of ASK1 inhibitor NQDI1 (4 μg/20 μl, i.t.) at 14 days after CCI injury significantly attenuated CCI-induced mechanical allodynia and thermal hyperalgesia ( n = 8). c , d Consecutive administration of ASK1 inhibitor NQDI1 (4 μg/20 μl, i.t.) at days 14, 15, and 16 after CCI injury significantly attenuated CCI-induced mechanical allodynia and thermal hyperalgesia ( n = 8). e , f NQDI1 (4 μg/20 μl, i.t.) decreased the expression of p-JNK and p-p38 induced by CCI but did not affect p-ERK expression in the spinal cords of rats. The lumbar spines (L1–L6) were collected and analyzed 2 h after the drug administration ( n = 4). A significant difference was revealed following one-way ANOVA (* P < 0.05, ** P < 0.01, *** P < 0.001 vs. control; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. CCI group; Bonferroni post hoc tests)
Article Snippet: Antibody for p-ASK1 (Thr845) (1:1000, bs-3031R) was purchased from Bioss (Woburn, MA).
Techniques: Expressing